News Release Details
Verrica Pharmaceuticals Announces Participation in the Jefferies 2018 London Healthcare Conference
A live audio webcast of the Jefferies 2018
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum contagiosum and in a Phase 2 clinical trial for the treatment of common warts.
Chief Financial Officer
484.453.3300 ext. 103
Source: Verrica Pharmaceuticals Inc.